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Of the 12 billion people who live in areas
where malaria occurs, 1500 million are es-
timated to become infected each year, and
as many as 1.2 million die as a direct result,
the majority of whom are children !5
years old. Additionally, some 10,000 trav-
elers from developed nations return home
with malaria annually. Resistance, both in
Plasmodium species to the first-line che-
motherapeutic agents and in the Anopheles
mosquito vectors to insecticides, is wide-
spread. The potential value of an anti-
malaria vaccine has long been recognized.
The malaria life cycle presents 3 sets of
targets for vaccine intervention, associat-
ed sequentially with invasion, erythrocyte
infection, and sexual reproduction in
the mosquito. However, malaria infec-
tion, clinical disease, and transmission all
would be prevented by a vaccine target-
ing only the exoerythrocytic (EEC) spo-
rozoite and liver stages. In the quest for
a malaria vaccine, the first significant
benchmark was set in 1967, when Ruth
Nussenzweig and colleagues [1] reported
that the injection of radiation-attenuated
sporozoites of the rodent malaria parasite,
Plasmodium berghei, was capable of in-
ducing protection against challenge in
190% of immunized mice. Subsequent
studies, in Nussenzweig’s lab and in oth-
ers, of rodent, monkey, and human forms
of malaria have established radiation-at-
tenuated sporozoites as the “gold stan-
dard” for malaria vaccination.
In a natural infection, sporozoites in-
jected into the skin by an infected mos-
quito travel through the bloodstream to
the liver sinusoids, where they actively
migrate through Kupffer cells and into
hepatocytes [2]. Inside a hepatocyte, the
sporozoite is sequestered within a para-
sitophorous vacuole, where it metamor-
phoses, feeds, and divides asexually into
numerous merozoites to form a maturing
liver schizont. Optimally irradiated spo-
rozoites also are able to invade hepatocytes
but fail to undergo nuclear division and
development into schizonts.
A series of parasite proteins, character-
istic initially of sporozoites and latterly of
developing liver and erythrocytic stages, is
expressed in the liver. Antibodies to pro-
teins expressed by the sporozoites and
early liver-stage parasites, together with
CD8+ T cells and natural killer cells, form
the core of the host immune response to
the EEC infection [3].
Until now, it had been assumed that the
protection induced by radiation-attenu-
ated malaria parasites was derived from
an extended period of expression of the
EEC-stage antigens by the intracellular
hepatocytic parasites. However, an ad-
ditional, alternative explanation was re-
cently suggested [4]: presentation of the
parasite antigens in the context of host
cell apoptosis. A host cell that is invaded
by a pathogen shows a natural proclivity
for undergoing apoptosis in an attempt
to prevent further development of the in-
vader and dissemination of the infection
to new host cells. Intracellular patho-
gens—viruses, bacteria, and protozoa—
have evolved a remarkable array of strat-
egies for circumventing or neutralizing
this host cell response. Attenuation in-
duced by radiation, it was reasoned, might
be capable of abrogating the ability of a
parasite to suppress the host cell’s inclina-
tion to undergo apoptosis. Thus, host cells
infected with irradiated parasites would die
by apoptosis and be phagocytosed and pro-
cessed by dendritic cells.
In this issue of the Journal of Infectious
Diseases, Leiriao et al. [5] present data that
support this hypothesis. Using the mouse
malaria parasite, P. yoelii, these authors
show that, after invasion of hepatocytes in
vivo by irradiated sporozoites, the infected
hepatocytes subsequently undergo apop-
tosis. This observation fits with the notion
that, with the inhibitors of host cell ap-
optosis disabled through irradiation of the
parasite, the infected hepatocyte dies as it
is programmed to do after invasion.
It seems likely that the apoptotic malaria
parasite–infected hepatocytes observed by
Leiriao et al. died through activation of the
intrinsic pathway of apoptosis rather than
the extrinsic death receptor–mediated or
granzyme/perforin pathways, but this re-
mains to be confirmed. The intrinsic
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pathway of apoptosis operates through
disruption of the mitochondrial outer
membrane and activation of caspase-9,
which then activates the executioner cas-
pases, caspase-3, -6, and -7. The extrin-
sic pathway is usually initiated through
activation of caspase-8 upstream of cas-
pase-3. Leiriao et al. demonstrate strong
activity of caspase-3 in the malaria-
infected apoptotic hepatocytes. Other
studies have reported that the immune
response to liver-stage parasites is not ab-
rogated in perforin-deficient or Fas-de-
ficient mice [6], suggesting that it is un-
likely that these pathways are involved.
The decline in the numbers of irradiated-
parasite–infected hepatocytes in Leiriao
et al.’s study began within a few hours of
sporozoite inoculation, and parasitized
host cell numbers had already fallen to
∼20% of initial numbers by 48 h after
inoculation. Hepatocyte apoptosis thus
precedes the appearance of parasite-re-
active CD8+ T cells, which become de-
tectable 48–72 h after inoculation [7],
further suggesting that the observed he-
patocyte apoptosis is unlikely to be me-
diated via the granzyme/perforin or ex-
trinsic pathways triggered by activated T
cells. Under the assumption that the ap-
optosis seen in Leiriao et al.’s mouse he-
patocytes does follow the intrinsic pathway,
this would be the first evidence that intra-
cellular parasites attenuated by irradiation
do fail to prevent the inherent drive of the
host cell to undergo apoptosis.
Irradiation is a powerful inducer of the
intrinsic pathway of apoptosis that oper-
ates through DNA damage and up-regu-
lated expression of p53, leading to mito-
chondrial disruption. This, at least, is the
pathway in mammalian cells. A process
very similar to apoptosis has been ob-
served in protozoa [8, 9]; however, since
the molecular machinery and the apop-
totic transduction pathway(s) are cur-
rently unknown for protozoa, it is not yet
possible to determine whether an apop-
totic death is also the ultimate demise of
irradiated sporozoites. Even if it did not
die as a result of radiation-induced ap-
optosis, the intracellular parasite might
also be disassembled coincidently with the
host cell contents by the host apoptotic
machinery. After invasion of a hepatocyte
by an irradiated sporozoite, both parasite
and host cell, or just the host cell, could
die by apoptosis. Either way, the apoptotic
hepatocyte would be flagged for phago-
cytosis; however, if the parasite died with-
out the concomitant apoptotic death of its
host hepatocyte, this antigen-presentation
pathway would not operate.
The work of Leiriao et al. additionally
provides evidence that liver dendritic cells
are recruited to phagocytose the hepato-
cyte corpses. This observation is also sig-
nificant, since data from other systems
have indicated that dendritic cells are im-
portant for the phagocytosis and process-
ing of apoptotic cell debris and cross-pre-
sentation of antigens for priming CD8+ T
cells [10, 11], and CD8+ T cells are critical
to the development of immunity against
an irradiated-sporozoite infection. The im-
petus for recruitment of dendritic cells,
as well as for their maturation, could be
provided by inflammatory mediators re-
leased by Kupffer cells and hepatocytes
wounded during the migration of spo-
rozoites within the liver sinusoids before
the hepatocyte of choice is selected [2],
as Leiriao et al. suggest, as well as by the
apoptotic hepatocytes themselves.
Cells that have undergone apoptosis as
a consequence of normal tissue growth or
development do not release “danger sig-
nals,” and the phagocytosis of these cells
does not usually lead to the induction of
immunity [12]. However, “stressed” ap-
optotic cells, particularly those expressing
heat shock proteins, are very effective
stimulators of dendritic cells and acti-
vators of T cells [13, 14]. It might be
reasonable to suspect that hepatocytes
infected with radiation-attenuated spo-
rozoites are stressed. However, even if
this is not the case, the parasite itself
could be a source of stress proteins and
other danger signals. Coincidentally, Lei-
riao et al. used Plasmodium Hsp70 to
monitor host cell infection and dendritic
cell phagocytosis. Danger signals of mi-
crobial or host cell origin can function
as adjuvant molecules; therefore, if cer-
tain molecules originating from the ir-
radiated sporozoites do assume the role
of danger signals, the vaccine organisms
could essentially provide their own adju-
vants, as can occur with immunization with
bacteria. Alternatively, the danger signals
could come from those wounded Kupffer
cells and hepatocytes traversed by the spo-
rozoites during invasion.
An issue related to vaccination using
irradiated sporozoites that remains con-
troversial is whether the induction of pro-
tective immunity occurs centrally, through
antigen processing in the spleen and
lymph nodes, or peripherally, at the sites
where sporozoite invasion of host cells
occurs. The data presented by Leiriao et
al. provide evidence that, in the liver, the
latter scenario is at least plausible. Others
may disagree, since it is thought that only
a minority of irradiated sporozoites ac-
tually reaches the liver. Local induction
of immunity to parasite antigens through
processing of apoptotic infected host cells
by dendritic cells could, thus, be just one
component of several diverse mechanisms
of antigen processing and presentation that
are activated after inoculation with irradi-
ated sporozoites. However, since hepatocyte
invasion is unique to the live attenuated
vaccine approach and immunization with
apoptotically derived antigens is increas-
ingly being recognized in several systems as
a potent method of inducing protective im-
munity, this mechanism, involving hepa-
tocyte apoptosis and dendritic cells, could
be what accounts for the “gold standard”
status of the radiation-attenuated–sporo-
zoite vaccine.
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